Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].
Eur J Cancer
; 119: 200-201, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-31301937
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2019
Type:
Article